They discover how to predict if a patient will have severe COVID-19

A scientific study announced Tuesday by an Australian university revealed that the impact of it can be predicted. COVID-19 in a patient and their immune response to infection through the effectiveness or fitness of lung cells.

SIGHT: Variante Delta is responsible for 84% of COVID-19 cases in Peru

The study investigated a marker of cellular fitness, known to identify suboptimal cells in patients who at the beginning of the pandemic, according to a statement from the Australian University of Queensland that participated in the study.

”We found that patients with acute lung injuries in the lower respiratory tract and in areas of cell death ”, said Arutha Kulasinghe, an expert from the University of Queensland, who participated in this study published on the medical portal EMBO Molecular Medicine.

SIGHT: European Medicines Agency begins evaluating Pfizer vaccine for children 5 to 11 years old

For the study, the researchers conducted an analysis post mortem from lung tissues infected by COVID-19 and found that the cellular fitness marker, which is part of the body’s process to kill unwanted cells,

In addition, the scientists found that this marker of cellular fitness was more important than age, inflammation, and coexisting diseases, in predicting health outcomes, such as hospitalization and death, in COVID-19 patients.

SIGHT: What should we know about vaccinating children and adolescents?

The scientists believe that results of the study, which was carried out together with the University of Copenhagen, could be useful in the early selection of patients who test positive for COVID-19, since the marker of cellular fitness

”The cellular fitness marker would allow medical teams to identify patients most likely to develop severe symptoms, offer a and earlier access to hospitalization and intensive care ”, said the expert from the University of Queensland.

• Variante Delta is responsible for 84% of COVID-19 cases in Peru
• What should we know about vaccinating children and adolescents?
• European Medicines Agency begins evaluating Pfizer vaccine for children 5 to 11 years old
• On the COVID-19 Vaccine Mix, by Elmer Huerta
• Third dose of the COVID-19 vaccine | What science says about its importance
• COVID-19 | FDA Experts Endorse Johnson & Johnson Vaccine Booster Dose
• COVID-19 | FDA Experts Recommend Third Dose of Moderna Vaccine
• When will a messenger RNA flu vaccine be ready?
• COVID-19 | A new method allows detecting the transmission of the coronavirus in hospitals
• Rapid antigen test is 80% effective at detecting COVID-19, study finds
• A new WHO research group may be “the last chance to know the origin of the coronavirus”
• PAHO on Peru’s decision to vaccinate adolescents: it should be done “only after vaccinating all adults”
• COVID-19: Booster Vaccine Combination Raises Antibodies, Preliminary Study Reveals
• Harassment and threats against scientists who speak of COVID-19 in the media
• Cuba tests in Italy the efficacy of its vaccine against COVID-19 Soberana Plus
• Hospital corridors may have higher viral loads than COVID-19 patient rooms
• EMA ends CureVac vaccine evaluation after trial cancellation
• COVID-19 | Russia says its Sputnik Light vaccine is 70% effective against Delta variant
• “Doctors treated my mother like a guinea pig”: scandal in Brazil over misuse of drugs against COVID-19

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);

.

Deshawn